Abstract:Despite a substantial global improvement in infant and child mortality from communicable diseases since the early 1990s there is now a growing burden of chronic disease in children and adolescents worldwide, mimicking the trend seen in the adult population. Chronic diseases in children and adolescents can affect all aspects of their well‐being and function with these burdens and their health‐related consequences often carried into adulthood. Up to one third of disability‐adjusted life years for children and adolescents globally are a result of chronic disease. This has profound implications for the broader family unit, communities, and health systems in which these children and young people reside. Models of chronic care delivery for children and adolescents with chronic disease have traditionally been adapted from adult models. There is a growing recognition that children and adolescents with chronic diseases have a unique set of healthcare needs. Their needs extend beyond disease education and management appropriate to the developmental stage of the child, to encompass psychological well‐being for the entire family and a holistic care approach focusing on the social determinants of health. It is for this reason that patient navigators have been proposed as a potential intervention to help fulfil this critical healthcare gap. Patient navigators are trained medical or non‐medical personnel (e.g. lay health workers, community health workers, nurses, or people with lived experience) who provide guidance for the patients (and their primary caregivers) as they move through complex (and often bewildering) medical and social systems. The navigator may deliver education, help to co‐ordinate patient care, be an advocate for the patient (and their primary caregivers), or combinations of these. Patient navigators can assist people with a chronic illness (especially those who are vulnerable or from a marginalised population, or both) to better understand their diagnoses, treatment options, and available resources. As there is considerable variation in the purpose, design, and target population of patient navigator programmes, there is a need to systematically review and summarise the existing literature on the effectiveness of navigator programmes in children and young adults with chronic disease. To assess the effectiveness of patient navigator programmes in children and adolescents with chronic diseases. We searched the Cochrane Library and Epistemonikos up to 20 January 2023 for related systematic reviews using search terms relevant to this review. We searched CENTRAL, MEDLINE, Embase, CINAHL EBSCO, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal, and ClinicalTrials.gov for primary studies. We included randomised controlled trials reporting the effect of patient navigator interventions on children and adolescents (aged 18 years or younger) with any chronic disease in hospital or community settings. Two review authors independently assessed the retrieved titles and abstracts, and where necessary, the full text to identify studies that satisfied the inclusion criteria. Two review authors extracted data using a standard data extraction form. We used a random‐effects model to perform a quantitative synthesis of the data. We used the I2 statistic to measure heterogeneity amongst the studies in each analysis. We indicated summary estimates as mean differences (MD), where studies used the same scale, or standardised mean differences (SMD), where studies used different scales, with 95% confidence intervals (CI). We used subgroup and univariate meta‐regression to assess reasons for between‐study differences. We used the Cochrane RoB 1 tool to assess the methodological quality of the included studies. We used GRADE to assess the certainty of the evidence. We included 17 studies (2895 randomised participants). All studies compared patient navigators with standard care. Most studies were at unclear or high risk of bias. Meta‐analysis was undertaken only for those studies that had the same duration of patient navigator intervention and follow‐up/reporting of outcome measures. The evidence is very uncertain about the effects of patient navigator programmes compared with standard care on self‐reported quality of life of children with chronic illness (SMD 0.63, 95% CI −0.20 to 1.47; I 2 = 96%; 4 studies, 671 participants; very low‐certainty evidence); parent proxy‐reported quality of life (SMD 0.09, 95% CI −2.21 to 2.40; I 2 = 99%; 2 studies, 309 participants; very low‐certainty evidence); or parents' or caregivers' quality of life (SMD −1.98, 95% CI −4.13 to 0.17; I 2 = 99%; 3 studies, 757 participants; very low‐certainty evidence). It is uncertain whether duration of patient navigator intervention accounts for any of the variances in the changes in quality of life. The evidence is very uncertain about -Abstract Truncated-

NAVKIDS2: a lesson in matching outcome measures to interventions

Baseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease

The randomized controlled trial (NAVKIDS2) of a patient navigator program created for children with chronic kidney disease

Patient navigator programmes for children and adolescents with chronic diseases

Patient Navigation: Addressing Social Challenges in Dialysis Patients.

Effects of prazosin on forearm resistance and capacitance vessels

Acetylsalicylic acid (ASA) in prevention of cancer

[Immunoglobulins and lysozyme in the supernatant of the sputum].

Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit

Process Evaluation of a Pilot Food Insecurity Resource Navigation Program Integrated Within Pediatric Primary Care: Utilizing RE-AIM to Inform Program Scale-up

Enhancing Quality of Life in African American Patients with Chronic Kidney Disease: An Evidence-Based Intervention

Impact of a health literacy sensitive model of care in outpatient nephrology dietetic clinics

Improving Transition of Care for Pediatric Patients With Chronic Kidney Disease: A Pilot Project

CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model

Orientation or training: an urgent issue for child psychiatry.

Outcome Measures of Clinical Trials in Pediatric Chronic Kidney Disease

Analysis of pigments from Roman wall paintings found in Vicenza.

Visions of Henkin

Development of a Health Insurance Navigation Program for Long-Term Childhood Cancer Survivors

Providers’ Views on a Community-Wide Patient Navigation Program

A Nurse-Coordinated Model of Care Versus Usual Care for Chronic Kidney Disease: Meta-Analysis